Razpipadon is a chemical compound under development as a pharmaceutical raw material. It is a dopamine receptor agonist intended for research into dementia-related apathy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1643462-93-4
Norglipin
pharmaceutical raw material
(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylsulfinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
pharmaceutical raw material
Iptacopan
pharmaceutical raw material
N-Desmethylquazepam
pharmaceutical raw material
6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethylpyrimidine-2,4-dione
ZXIPVZWZRQCIRW-UHFFFAOYSA-N
CC1=C(C=CC(=C1)OC2=C(C=CC=N2)OC(F)F)C3=C(C(=O)NC(=O)N3C)C